Jing Jing

Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial

Laura Kist de Ruijter, Pim P. van de Donk, Jahlisa S. Hooiveld-Noeken et al. · Nature Medicine · 2022 · 112 citations · Full text

Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial

Lihua E. Budde, Adam J. Olszewski, Sarit Assouline et al. · Nature Medicine · 2023 · 76 citations · Full text

The associations of air pollution and socioeconomic factors with esophageal cancer in China based on a spatiotemporal analysis

Peng Li, Jing Jing, Wen‐Wen Guo et al. · Environmental Research · 2020 · 30 citations

Socioeconomic Factors, Epidemiology, Esophageal Cancer +9

Fixed Duration Mosunetuzumab Plus Polatuzumab Vedotin Has Promising Efficacy and a Manageable Safety Profile in Patients with BTKi Relapsed/Refractory Mantle Cell Lymphoma: Initial Results from a Phase Ib/II Study

Michael Wang, Sarit Assouline, Manali Kamdar et al. · Blood · 2023 · 29 citations

Spatial distribution characteristics of tumor marker CA724 reference values in China

Jing Jing, Ge Miao, Ziqi Yang et al. · Cancer Medicine · 2019 · 28 citations · Full text

Environmental Monitoring, Disease Mapping, Pathology +19